Synapse - Works

Results (5712)

The ECHELON-2 Trial: 5-year exploratory subgroup analyses of a randomized, double-blind, phase 3 study of brentuximab vedotin and CHP (A + CHP) vs CHOP in frontline treatment of pts with CD30-positive peripheral T-cell lymphoma

Meeting Abstract

Horwitz, S. M.; Savage, K. J.; Illidge, T.; Plyer, S. P.; Advani, R.; Shustov, A. R.; Bartlett, N. L.; Pro, B.; Jacobsen, E. D.; Koch, R.; more...
Blood (2021)

Fulltext@MSK | Save

Phase 2a study of the dual SYK/JAK inhibitor cerdulatinib (ALXN2075) as monotherapy in patients with relapsed/refractory peripheral T-cell lymphoma

Meeting Abstract

Horwitz, S. M.; Feldman, T. A.; Ye, J. C.; Khodadoust, M. S.; Munoz, J.; Hamlin, P. A.; Kim, Y. H.; Wilcox, R. A.; Patel, M. R.; Coffey, G. P.; more...
Blood (2021)

Fulltext@MSK | Save

Updates from ongoing, first-in-human phase 1 dose escalation and expansion study of TTI-621, a novel biologic targeting CD47, in patients with relapsed or refractory hematologic malignancies

Meeting Abstract

Horwitz, S. M.; James, M. F.; Maris, M.; Lue, J. K.; Sawas, A.; Okada, C.; Feldman, T. A.; Sokol, L.; Mei, M.; Flinn, I. W.; more...
Blood (2021)

Fulltext@MSK | Save

Nanatinostat (Nstat) and valganciclovir (VGCV) in relapsed/refractory (R/R) Epstein-Barr virus-positive (EBV (+)) lymphomas: Final results from the phase 1b/2 VT3996-201 study

Meeting Abstract

Haverkos, B. M.; Alpdogan, O.; Baiocchi, R.; Brammer, J. E.; Feldman, T. A.; Capra, M.; Brem, E. A.; Nair, S. M.; Scheinberg, P.; Pereira, J.; more...
Blood (2021)

Fulltext@MSK | Save

T-cell lymphomas: Online education significantly improves clinicians' knowledge of therapeutic advances

Meeting Abstract

Heller, E. J.; Williams, S. L.; Smith, K. P.; Horwitz, S. M.
Blood (2021)

Fulltext@MSK | Save

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): A long-term follow-up of the randomized, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

Meeting Abstract

Hermine, O.; Jiang, L.; Walewski, J.; Bosly, A.; Szymczyk, M.; Thieblemont, C.; Pott, C.; Salles, G.; Feugier, P.; Hübel, K.; more...
Blood (2021)

Fulltext@MSK | Save

Risks for hospitalization and death among patients with blood disorders from the ASH RC COVID-19 Registry for Hematology

Meeting Abstract

Hicks, L. K.; Redd, R. A.; Anderson, K. C.; Desai, P.; Dolan, B.; Goldberg, A. D.; Narendra, V.; Neuberg, D. S.; Radhakrishnan, V.; Sehn, L. H.; more...
Blood (2021)

Fulltext@MSK | Save

Phase 2a study of the dual SYK/JAK inhibitor cerdulatinib (ALXN2075) as monotherapy or in combination with rituximab in patients with relapsed/refractory follicular lymphoma

Meeting Abstract

Hamlin, P. A.; Patel, M. R.; Stevens, D.; Hess, B. T.; Munoz, J.; Feldman, T. A.; Smith, S. M.; Coffey, G. P.; Osman, M.; Holland, J. S.; more...
Blood (2021)

Fulltext@MSK | Save

Intensification of chemotherapy using a modified BFM backbone for children, adolescents and young adults with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LL) identifies highly chemorefractory patients who benefit from allogeneic hematopoietic stem cell transplantation

Meeting Abstract

Harker-Murray, P.; Wood, B. L.; Devidas, M.; Chen, Z.; Schechter-Finkelstein, T.; Hayashi, R. J.; August, K. J.; Dunsmore, K. P.; Hermiston, M. L.; Horton, T. M.; more...
Blood (2021)

Fulltext@MSK | Save

Notable patterns in the genomic landscape of adult T-cell leukemia/lymphoma encountered in HTLV-1 endemic Western world regions

Meeting Abstract

Gru, A. A.; Snowden, C.; Williams, E.; Barrionuevo, C.; Sanches, J.; Battistella, M.; Mo, S.; Pulitzer, M.; Bhagat, G.; Servitje, O.; more...
Blood (2021)

Fulltext@MSK | Save